Hambleton P, Carman JA, Melling J: Anthrax: the disease in relation to vaccines. Vaccine. 1984, 2: 125-132. 10.1016/0264-410X(84)90003-3.
Article
PubMed
CAS
Google Scholar
Koya V, Moayeri M, Leppla SH, Daniell H: Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge. Infect Immun. 2005, 73: 8266-8274. 10.1128/IAI.73.12.8266-8274.2005.
Article
PubMed
CAS
PubMed Central
Google Scholar
Wright G, Green TW, Kanode JR: Studies on immunity in anthrax. V. Immunizing activity of alum-precipitated protective antigen. J Immunol. 1954, 73: 387-391.
PubMed
CAS
Google Scholar
Ascenzi P, Visca P, Ippolito G, Spallarossa A, Bolognesi M, Montecucco C: Anthrax toxin: a tripartite lethal combination. FEBS Lett. 2002, 531: 384-388. 10.1016/S0014-5793(02)03609-8.
Article
PubMed
CAS
Google Scholar
Collier RJ, Young JAT: Anthrax toxin. Annu Rev Cell Dev Biol. 2003, 19: 45-70. 10.1146/annurev.cellbio.19.111301.140655.
Article
PubMed
CAS
Google Scholar
Ezzell JW, Abshire TG, Panchal R, Chabot D, Bavari S, Leffel EK, Purcell B, Friedlander AM, Ribot WJ: Association of Bacillus anthracis capsule with lethal toxin during experimental infection. Infect Immun. 2009, 77 (2): 749-755. 10.1128/IAI.00764-08.
Article
PubMed
CAS
PubMed Central
Google Scholar
Jang J, Cho M, Chun JH, Cho MH, Park J, Oh HB, Yoo CK, Rhie G: The poly-γ-d-glutamic acid capsule of Bacillus anthracis enhances lethal toxin activity. Infect Immun. 2011, 79: 3846-3854. 10.1128/IAI.01145-10.
Article
PubMed
CAS
PubMed Central
Google Scholar
Sterne M: The effects of different carbon dioxide concentrations on the growth of virulent anthrax strains. pathogenicity and immunity tests on guinea-pigs and sheep with anthrax variants derived from virulent strains. Onderstepoort J Vet. 1937, 9: 49-67.
CAS
Google Scholar
Mikesell P, Ivins BE, Ristroph JD, Dreier TM: Evidence for plasmid-mediated toxin production in Bacillus anthracis. Infect Immun. 1983, 39: 371-376.
PubMed
CAS
PubMed Central
Google Scholar
Personeus G, Cooper MS, Percival RC: Studies on an anthrax vaccine prepared from nonencapsulated variants of Bacillus anthracis. Am J Vet Res. 1956, 17: 153-156.
PubMed
CAS
Google Scholar
Ivins BE, Ezzell JW, Jemski J, Hedlund KW, Ristroph JD, Leppla SH: Immunization studies with attenuated strains of Bacillus anthracis. Infect Immun. 1986, 52: 454-458.
PubMed
CAS
PubMed Central
Google Scholar
Sterne M: The use of anthrax vaccines prepared from avirulent (uncapsulated) variants of Bacillus anthracis. Onderstepoort J Vet Sci Anim Indust. 1939, 13: 307-312.
Google Scholar
Lincoln RE, Walker JS, Klein F: Value of field data for extrapolation in anthrax. Technical manuscript 346. 1967, Maryland: Department of the Army, USA
Google Scholar
Turnbull PC, Doganay M, Lindeque PM, Aygen B, McLaughlin J: Serology and anthrax in humans, livestock and Etosha National Park wildlife. Epidemiol Infect. 1992, 108: 299-313. 10.1017/S0950268800049773.
Article
PubMed
CAS
PubMed Central
Google Scholar
Belton FC, Strange RE: Studies on a protective antigen produced in vitro from Bacillus anthracis: medium and methods of production. Br J Exp Pathol. 1954, 35: 144-152.
PubMed
CAS
PubMed Central
Google Scholar
Puziss M, Wright GG: Studies on immunity in anthrax IV: Factors influencing elaboration of the protective antigen of Bacillus anthracis in chemically defined media. J Bacteriol. 1954, 68: 474-482.
PubMed
CAS
PubMed Central
Google Scholar
Turnbull PC, Broster MG, Carman JA, Manchee RJ, Melling J: Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Infect Immun. 1986, 52: 356-363.
PubMed
CAS
PubMed Central
Google Scholar
Johnson-Winegar A: Comparison of enzyme-linked immunosorbent and indirect hemagglutination assays for determining anthrax antibodies. J Clin Microbiol. 1984, 20: 357-361.
PubMed
CAS
PubMed Central
Google Scholar
Hahn UK, Aichler M, Boehm R, Beyer W: Comparison of the immunological memory after DNA vaccination and protein vaccination against anthrax in sheep. Vaccine. 2006, 24: 4595-4597. 10.1016/j.vaccine.2005.08.025.
Article
PubMed
CAS
Google Scholar
Shakya KP, Hugh-Jones ME, Elzer PH: Evaluation of immune response to orally administered Sterne strain 34 F2 anthrax vaccine. Vaccine. 2007, 25: 5374-5377. 10.1016/j.vaccine.2007.05.003.
Article
PubMed
CAS
Google Scholar
Kelly CD, O’Loughlin C, Gelder FB, Peterson JW, Sower LE, Cirino NM: Rapid generation of an anthrax immunotherapeutic from goats using a novel non-toxic muramyl dipeptide adjuvant. J Immune Based Ther Vaccines. 2007, 5: 11-10.1186/1476-8518-5-11.
Article
PubMed
PubMed Central
Google Scholar
Reuveny S, White MD, Adar YY, Kafri Y, Altboum Z, Gozes Y, Kobiler D, Shafferman A, Velan B: Search for correlates of protective immunity conferred by anthrax vaccine. Infect Immun. 2001, 69: 2888-2893. 10.1128/IAI.69.5.2888-2893.2001.
Article
PubMed
CAS
PubMed Central
Google Scholar
Pitt ML, Little SF, Ivins BE, Fellows P, Barth J, Hewetson J, Gibbs P, Dertzbaugh M, Friedlander AM: In vitro correlate of immunity in a rabbit model of inhalational anthrax. Vaccine. 2001, 19: 4768-4773. 10.1016/S0264-410X(01)00234-1.
Article
PubMed
CAS
Google Scholar
Parreiras PM, Sirota LA, Wagner LD, Menzies SL, Arciniega JL: Comparability of ELISA and toxin neutralization to measure immunogenicity of Protective Antigen in mice, as part of a potency test for anthrax vaccines. Vaccine. 2009, 27: 4537-4542. 10.1016/j.vaccine.2009.05.045.
Article
PubMed
CAS
Google Scholar
Hering D, Thompson W, Hewetson J, Little S, Norris S, Pace-Templeton J: Validation of the anthrax lethal toxin neutralization assay. Biologicals. 2004, 32: 17-27. 10.1016/j.biologicals.2003.09.003.
Article
PubMed
CAS
Google Scholar
Zmuda JF, Zhang L, Richards T, Pham Q, Zukauskas D, Pierre JL, Laird MW, Askins J, Choi GH: Development of an edema factor-mediated cAMP-induction bioassay for detecting antibody-mediated neutralization of anthrax protective antigen. J Immunol Methods. 2005, 298: 47-60. 10.1016/j.jim.2004.12.022.
Article
PubMed
CAS
Google Scholar
Omland KS, Brys A, Lansky D, Clement K, Lynn F, and the Participating Laboratories: Interlaboratory comparison of results of an anthrax lethal toxin neutralization assay for assessment of functional antibodies in multiple species. Clin Vaccine Immunol. 2008, 15: 946-953. 10.1128/CVI.00003-08.
Article
PubMed
CAS
PubMed Central
Google Scholar
DeSilva B, Smith W, Weiner R, Kelley M, Smolec JM, Lee B, Khan M, Tacey R, Hill H, Celniker A: Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm Res. 2003, 20: 1885-1900.
Article
PubMed
CAS
Google Scholar
Koehler S, Huwar T, Baillie L, Beyer W: Vaccination of NMRI mice against Bacillus anthracis using DNA and protein based acellular vaccine candidates and novel adjuvants. International conference on Bacillus anthracis, B. cereus and B. thuringiensis (Poster session). 2011, Bruges, 102-
Google Scholar
Little S, Webster W, Norris S, Andrews G: Evaluation of an anti-rPA IgG ELISA for measuring the antibody response in mice. Biologicals. 2004, 32: 62-69. 10.1016/j.biologicals.2004.02.001.
Article
PubMed
CAS
Google Scholar
Miura K, Orcutt AC, Muratova OV, Miller LH, Saul A, Long CA: Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines. Vaccine. 2008, 26: 193-200. 10.1016/j.vaccine.2007.10.064.
Article
PubMed
CAS
PubMed Central
Google Scholar
Gu M, Hine PM, James Jackson W, Giri L, Nabors GS: Increased potency of BioThrax anthrax vaccine with the addition of the C-class CpG oligonucleotide adjuvant CPG 10109. Vaccine. 2007, 25: 526-534. 10.1016/j.vaccine.2006.07.056.
Article
PubMed
CAS
Google Scholar
Leppla SH, Robbins JB, Schneerson R, Shiloach J: Development of an improved vaccine for anthrax. J Clin Invest. 2002, 110: 141-144.
Article
PubMed
CAS
PubMed Central
Google Scholar
Welkos S, Vietri N, Gibbs P: Non-toxigenic derivatives of the Ames strain of Bacillus anthracis are fully virulent for mice: role of plasmid pXO2 and chromosome in strain-dependent virulence. Microb Pathog. 1993, 14: 381-388. 10.1006/mpat.1993.1037.
Article
PubMed
CAS
Google Scholar
Cybulski RJ, Sanz P, O’Brien AD: Anthrax vaccination strategies. Mol Aspects Med. 2009, 30: 490-10.1016/j.mam.2009.08.006.
Article
PubMed
CAS
PubMed Central
Google Scholar
Welkos S, Little S, Friedlander A, Fritz D, Fellows P: The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Microbiol. 2001, 147: 1677-1685.
Article
CAS
Google Scholar
Baillie LW, Rodriguez AL, Moore S, Atkins HS, Feng C, Nataro JP, Pasetti MF: Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime boost immunization strategy. Vaccine. 2008, 26: 6083-6091. 10.1016/j.vaccine.2008.09.010.
Article
PubMed
CAS
PubMed Central
Google Scholar
Findlay JWA, Dillard RF: Appropriate calibration curve fitting in ligand binding assays. AAPS J. 2007, 9: 260-267. 10.1208/aapsj0902029.
Article
Google Scholar
Karnes HT, March C: Calibration and validation of linearity in chromatographic biopharmaceutical analysis. J Pharm Biomed Anal. 1991, 9: 911-918. 10.1016/0731-7085(91)80022-2.
Article
PubMed
CAS
Google Scholar
Smith WC, Sittampalam GS: Conceptual and statistical issues in the validation of analytic dilution assays for pharmaceutical applications. J Biopharm Stat. 1998, 8: 509-532. 10.1080/10543409808835257.
Article
PubMed
CAS
Google Scholar
Plikaytis BD, Turner S, Gheesling L, Carlone G: Comparisons of standard curve-fitting methods to quantitate Neisseria meningitidis group A polysaccharide antibody levels by enzyme-linked immunosorbent assay. J Clin Microbiol. 1991, 29: 1439-1446.
PubMed
CAS
PubMed Central
Google Scholar
Vogt RV, Phillips DL, Omar Henderson L, Whitfield W, Spierto FW: Quantitative differences among various proteins as blocking agents for ELISA microtiter Plates. J Immunol Methods. 1987, 101: 43-50. 10.1016/0022-1759(87)90214-6.
Article
PubMed
CAS
Google Scholar
Weiss S, Kobiler D, Levy H, Marcus H, Pass A, Rothschild N, Altboum Z: Immunological correlates for protection against intranasal challenge of Bacillus anthracis spores conferred by a protective antigen-based vaccine in rabbits. Infect Immun. 2006, 74: 394-398. 10.1128/IAI.74.1.394-398.2006.
Article
PubMed
CAS
PubMed Central
Google Scholar
Little SF, Ivins BE, Fellows PF, Pitt MLM, Norris SLW, Andrews GP: Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine. Vaccine. 2004, 3-4: 422-430.
Article
Google Scholar
Peachman KK, Rao M, Alving CR, Burge R, Leppla SH, Rao VB, Matyas GR: Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen. Infect Immun. 2006, 74: 794-797. 10.1128/IAI.74.1.794-797.2006.
Article
PubMed
CAS
PubMed Central
Google Scholar
Turnbull PC, Tindall BW, Coetzee JD, Conradie CM, Bull RL, Lindeque PM, Huebschle OJ: Vaccine-induced protection against anthrax in cheetah (Acinonyx jubatus) and black rhinoceros (Diceros bicornis). Vaccine. 2004, 22: 3340-3347. 10.1016/j.vaccine.2004.02.037.
Article
PubMed
CAS
Google Scholar
O’Connell M, Belanger B, Haaland P: Calibration and assay development using the four-parameter logistic model. Chemometrics Intellig Lab Syst. 1993, 20: 97-114. 10.1016/0169-7439(93)80008-6.
Article
Google Scholar